Skip to main content
Top
Published in: Clinical Rheumatology 6/2010

01-06-2010 | Original Article

Group visits for rheumatoid arthritis patients: a pilot study

Authors: Kam Shojania, Matthew Ratzlaff

Published in: Clinical Rheumatology | Issue 6/2010

Login to get access

Abstract

This pilot study explored the feasibility of a group visit model for patients with rheumatoid arthritis (RA) and for medical staff at a private practice. RA patients were invited to attend six 3.5-h-long group visit sessions held once per month at a wellness center. Each included group discussion, individual patient examinations, interactive question, and answer periods, and topic-specific presentations from various health professionals. Nineteen of the 24 RA patients invited to the group visits agreed to attend, and 13 to 15 were present at any given session. Participants expressed a high level of satisfaction in evaluation forms completed at the end of the last session. Group visits allowed the rheumatologist to spend more time providing advice for various health issues and eliminated the need to repeat advice about common issues. This group visit model is feasible for motivated RA patients who can meet the time commitment involved.
Literature
1.
go back to reference Health Canada (2003) Arthritis in Canada: an ongoing challenge. Health Canada, Ottawa Health Canada (2003) Arthritis in Canada: an ongoing challenge. Health Canada, Ottawa
3.
go back to reference Jaber R, Braksmajer A, Trilling JS (2006) Group visits: a qualitative review of current research. J Am Board Fam Med 19:276–290CrossRefPubMed Jaber R, Braksmajer A, Trilling JS (2006) Group visits: a qualitative review of current research. J Am Board Fam Med 19:276–290CrossRefPubMed
5.
go back to reference Jaber R, Braksmajer A, Trilling J (2006) Group visits for chronic illness care: models, benefits and challenges. Fam Pract Manag 13:37–40PubMed Jaber R, Braksmajer A, Trilling J (2006) Group visits for chronic illness care: models, benefits and challenges. Fam Pract Manag 13:37–40PubMed
6.
go back to reference Masley S, Sokoloff J, Hawes C (2000) Planning group visits for high-risk patients. Fam Pract Manag 7:33–37PubMed Masley S, Sokoloff J, Hawes C (2000) Planning group visits for high-risk patients. Fam Pract Manag 7:33–37PubMed
8.
go back to reference Clancy DE, Dismuke CE, Magruder KM et al (2008) Do diabetes group visits lead to lower medical care charges? Am J Manag Care 14:39–44PubMed Clancy DE, Dismuke CE, Magruder KM et al (2008) Do diabetes group visits lead to lower medical care charges? Am J Manag Care 14:39–44PubMed
9.
go back to reference Spann SJ (2004) Task Force Report 6. Report on financing the new model of family medicine. Ann Fam Med 2:S1–S21CrossRefPubMed Spann SJ (2004) Task Force Report 6. Report on financing the new model of family medicine. Ann Fam Med 2:S1–S21CrossRefPubMed
10.
go back to reference Li LC, Badley EM, MacKay C et al (2008) An evidence-informed, integrated framework for rheumatoid arthritis care. Arth Rheum (Arth Care Res) 59:1171–1183CrossRef Li LC, Badley EM, MacKay C et al (2008) An evidence-informed, integrated framework for rheumatoid arthritis care. Arth Rheum (Arth Care Res) 59:1171–1183CrossRef
Metadata
Title
Group visits for rheumatoid arthritis patients: a pilot study
Authors
Kam Shojania
Matthew Ratzlaff
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2010
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-010-1379-5

Other articles of this Issue 6/2010

Clinical Rheumatology 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.